Image Ben Hargreaves Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced. Sales & Marketing All eyes remain on US government patent dispute with Gilead A high-stakes court battle is currently being fought in the US, with the government accusing a big pharma company of patent infringement for the first time. Sales & Marketing Pandemic caused vaccine confidence to fall even further Research has shown that vaccine hesitancy is on the rise globally. R&D Oncology R&D hits new heights, but that creates problems The number of people globally who are being treated for cancer is steadily going up each year. Load more results
Sales & Marketing ADHD medication scarcity adds to questions on US supply chai... Ben Hargreaves looks into why ADHD medicines are still suffering shortages nearly a year after first being announced.
Sales & Marketing All eyes remain on US government patent dispute with Gilead A high-stakes court battle is currently being fought in the US, with the government accusing a big pharma company of patent infringement for the first time.
Sales & Marketing Pandemic caused vaccine confidence to fall even further Research has shown that vaccine hesitancy is on the rise globally.
R&D Oncology R&D hits new heights, but that creates problems The number of people globally who are being treated for cancer is steadily going up each year.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
